longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Aethlon Medical

AEMD

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -0.36, within the reasonable range, cheaper than 29.68% of the time in the past 5 years, and the industry ranks 63/175, the industry Median -0.96.

-0.361xP/E
$1.56Stock price
$-4.32Earnings per share
-0.361xP/E
Stock price$1.56Earnings per share$-4.32

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-0.52x
Typical range
-1.34x–-0.30x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
011223344

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.76x141.71%$12.50B
GKOSUSGlaukos
-53.44x75.34%$10.05B
TFXUSTeleflex
-5.42x118.39%$5.59B
PLSEUSPulse Biosciences
-48.49x27.55%$3.88B
IRTCUSIRhythm
-266.79x71.96%$3.72B
AXGNUSAxogen
-67.07x31.62%$2.25B
BFLYUSButterfly Network
-25.33x34.41%$1.90B
ASSTUSStrive
-1.91x63.26%$1.86B
NVCRUSNovocure
-12.03x2.52%$1.79B
KMTSUSKestra Medical Tech
-10.50x5.19%$1.38B
ATECUSAlphatec
-12.41x41.67%$1.37B
DRTSUSAlpha Tau Medical
-14.40x--$1.33B
TNDMUSTandem Diabetes
-20.12x77.82%$1.27B
IARTUSIntegra LifeSciences
-167.00x109.50%$1.21B
AORTUSArtivion
-376.63x266.67%$1.20B
PRCTUSPROCEPT BioRobotics
-10.47x3.47%$1.15B
ENOVUSEnovis
-0.96x100.97%$1.06B
CBLLUSCeribell
-13.62x35.15%$899.20M
QDELUSQuidelOrtho
-0.79x75.33%$833.19M
SIBNUSSI-BONE
-56.05x8.85%$820.18M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.